Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI

by Sofia Ramiro, Alexandre Sepriano, Jose Marona, Santiago Rodrigues-Manica, Fernando Pimentel-Santos, Ana Filipa Mourão, Nélia Gouveia, Jaime Cunha Branco, Filipe Vinagre, João Tavares-Costa, João Rovisco, Miguel Bernardes, Nathalie Madeira, Rita Cruz-Machado, Raquel Roque, Joana Leite Silva, Mary Lucy Marques, Raquel Miriam Ferreira
Published 2020-05-01

CHANGE OF ACTIVITY, FUNCTIONAL CLASS, AND SPINAL MOBILITY IN ANKYLOSING SPONDYLOSIS DURING THERAPY WITH DIFFERENT PHARMACOLOGICAL AGENTS

by M. Ivanova, R. Stoilov, S. G. Radenska-Lopovok, I. Manolova
Published 2014-06-01

Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?

by Santiago Rodrigues Manica, Alexandre Sepriano, Fernando Pimentel-Santos, Nélia Gouveia, Anabela Barcelos, Jaime C. Branco, Miguel Bernardes, Raquel Miriam Ferreira, Elsa Vieira-Sousa, Sofia Barreira, Filipe Vinagre, Raquel Roque, Helena Santos, Nathalie Madeira, João Rovisco, Alexandra Daniel, Sofia Ramiro
Published 2020-08-01

Effects of tapering tumor necrosis factor inhibitor on the achievement of inactive disease in patients with axial spondyloarthritis: a nationwide cohort study

by Jun Won Park, Hyoun-Ah Kim, Kichul Shin, Yong-Beom Park, Tae-Hwan Kim, Yeong Wook Song, Eun Young Lee
Published 2019-07-01

Disease activity guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis: a prospective, randomized, open-label,...

by Ting Zhang, Jianing Zhu, Dongyi He, Xiaowei Chen, Hongzhi Wang, Ying Zhang, Qin Xue, Weili Liu, Guangbo Xiang, Yasong Li, Zhongming Yu, Huaxiang Wu
Published 2020-05-01

OPTIMIZING EXISTING TOOLS FOR REACHING AN ADEQUATE DISEASE CONTROL IN PATIENTS WITH SPONDYLOARTHRITIS

by Claudia Deaconu, Daniela Opris, Diana Mazilu, Laura Groseanu, Andreea Borangiu, Saulescu Ioana, Alexandra Peltea, Magdalena Negru, Cosmin Constantinescu, Violeta Vlad, Violeta Bojinca, Andra Balanescu, Denisa Predeteanu, Ruxandra Ionescu
Published 2016-06-01

Gender difference in ASAS HI among patients with ankylosing spondylitis.

by Hsin-Hua Chen, Yi-Ming Chen, Kuo-Lung Lai, Tsu-Yi Hsieh, Wei-Ting Hung, Ching-Tsai Lin, Chih-Wei Tseng, Kuo-Tung Tang, Yin-Yi Chou, Yi-Da Wu, Chin-Yin Huang, Chia-Wei Hsieh, Wen-Nan Huang, Yi-Hsing Chen
Published 2020-01-01

Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian Ankylosing Spondylitis Patients

by NAGMA BANSAL, LALIT DUGGAL, NEERAJ JAIN
Published 2017-09-01

Efficacy of short term non steroidal anti-inflammatory drugs in Indian patients with axial spondyloarthritis

by Shubha Bhalla, Shallu Verma, Anand Narayan Malaviya
Published 2018-01-01

Stable high interleukin-17A concentration in patients with ankylosing spondylitis treated with tumor necrosis factor-α inhibitors during a year

by I Z Gaydukova, A P Rebrov, A V Aparkina, E V Khondkaryan
Published 2017-04-01

The serum C-reactive protein to prealbumin ratio and fibrinogen to prealbumin ratio are two relevant indicators for evaluating the disease activity of ankylosing spondylitis

by Kai Zhang, Junhao Wang, Jinhong Chen, Zhi Li, Zhaohui Lou
Published 2021-05-01

Active ankylosing spondylitis increases blood loss during total hip arthroplasty for a stiff hip joint

by Yong Hu, Wei-Zhou Jiang, Cheng-Long Pan, Tao Wang
Published 2020-04-01

Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial

by Désirée van der Heijde, Joachim Sieper, Walter P. Maksymowych, Robert G. Lambert, Su Chen, Maja Hojnik, Jaclyn K. Anderson, Aileen L. Pangan
Published 2018-03-01

Magnetic resonance tomography capabilities and limitations in managing the efficacy of treatment with biological disease modifying anti-rheumatic drugs in ankylosing spondylitis

by P. A. Shesternya, O. D. Gritsenko, P. A. Astanin, A. Yu. Stepanenko, N. V. Popov
Published 2021-04-01

Secukinumab treatment in spondyloarthritis: Retention rate and effectiveness data at 12 months – data from the Romanian Registry of Rheumatic Diseases

by Corina Mogosan, Ruxandra Ionescu, Simona Rednic, Magda Parvu, Elena Rezus, Catalin Codreanu
Published 2020-12-01

Balance and falls in axial Spondyloarthritis: a cross sectional study

by Kerilyn Brenda Mewes, Betania Longo, Ana Paula Beckhauser Campos, Juliana Simioni, Thelma Larocca Skare
Published 2019-10-01

Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis

by I Z Gaydukova, A P Rebrov
Published 2015-03-01

Efficacy and safety of intravenous methylprednisolone in the treatment of patients with active ankylosing spondylitis: Results of a 12-week, prospective, open-label, pilot (METALL)...

by I Z Gaydukova, A P Rebrov, D A Poddubnyi
Published 2015-05-01

Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort

by Francesca Ometto, Augusta Ortolan, Davide Farber, Mariagrazia Lorenzin, Giulia Dellamaria, Giacomo Cozzi, Marta Favero, Romina Valentini, Andrea Doria, Roberta Ramonda
Published 2021-08-01

Topographic MRI evaluation of the sacroiliac joints in patients with axial spondyloarthritis

by Laís Uyeda Aivazoglou, Orlando Rondan Zotti, Marcelo de Medeiros Pinheiro, Moacir Ribeiro de Castro Junior, Andrea Puchnick, Artur da Rocha Corrêa Fernandes, Eloy de Ávila Fernandes